| Literature DB >> 24626207 |
Sa McNeil1, V Shinde, M Andrew, Tf Hatchette, J Leblanc, A Ambrose, G Boivin, Wr Bowie, F Diaz-Mitoma, M Elsherif, K Green, F Haguinet, S Halperin, B Ibarguchi, K Katz, J Langley, P Lagace-Wiens, B Light, M Loeb, J McElhaney, D Mackinnon-Cameron, Ae McCarthy, M Poirier, J Powis, D Richardson, M Semret, S Smith, D Smyth, G Stiver, S Trottier, L Valiquette, D Webster, L Ye, A McGeer.
Abstract
During the 2013/14 influenza season in Canada, 631 of 654 hospitalisations for laboratory-confirmed influenza enrolled in sentinel hospitals were due to Influenza A. Of the 375 with known subtype, influenza A(H1N1) accounted for 357. Interim unmatched vaccine effectiveness adjusted for age and presence of one or more medical comorbidities was determined by test-negative case-control design to be 58.5% (90% confidence interval (CI): 43.9-69.3%) overall and 57.9% (90% CI: 37.7-71.5) for confirmed influenza A(H1N1).Entities:
Mesh：
Substances：
Year: 2014 PMID： 24626207 DOI： 10.2807/1560-7917.es2014.19.9.20729
Source DB: PubMed Journal: Euro Surveill ISSN： 1025-496X